Asrat E. Kahsay

Asrat E. Kahsay

Auto-generated profile, based on publicly available information

Asrat E. Kahsay

Department of Medical Sciences and Laboratory for Technologies of Advanced Therapies (LTTA), University of Ferrara, 44121 Ferrara, Italy

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2022 in Biology
Verified
Journal Article
Open access
PDF file
Esmaa BouhamidaEsmaa Bouhamida
Esmaa Bouhamida
Giampaolo MorcianoGiampaolo Morciano
Giampaolo Morciano
Mariasole PerroneMariasole Perrone
Mariasole Perrone
AKAsrat E. Kahsay
Asrat E. Kahsay
MSMario Della Sala
Mario Della Sala
Simone PatergnaniSimone Patergnani
Simone Patergnani
Cardiovascular diseases (CVDs) and cancer continue to be the primary cause of mortality worldwide and their pathomechanisms are a complex and multifactorial process. Insufficient oxygen availability (hypoxia) plays critical roles in the pathogenesis of both CVDs and cancer diseases, and hypoxia-inducible factor 1 (HIF-1), the main sensor of hypoxia, acts as a central regulator of multiple target genes in the human body. Accumulating evidence demonstrates that mitochondria are the major target of hypoxic injury, the most common source of reactive oxygen species during hypoxia and key elements for inflammation regulation during the development of both CVDs and cancer. Taken together, observations propose that hypoxia, mitochondrial abnormality, oxidative stress, inflammation in CVDs, and cancer are closely linked. Based upon these facts, this review aims to deeply discuss these intimate relationships and to summarize current significant findings corroborating the molecular mechanisms and potential therapies involved in hypoxia and mitochondrial dysfunction in CVDs and cancer.